NEWARK, Del, Dec. 13, 2022 (GLOBE NEWSWIRE) -- A recently published study by FMI expects the global arterial cannula market to augment at a 6.6% CAGR from 2022 to 2032. By the end of the said ...

The global arterial cannula market has witnessed remarkable growth, reaching a market value of USD 21 billion in 2023. With a robust compound annual growth rate (CAGR) of 6.6%, this market is ...

The global arterial cannula market is anticipated to grow at a CAGR of around 7% during the forecast period. Growth in the market is driven by the rising prevalence of cardiovascular and chronic ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...

Terumo Cardiovascular Systems (Terumo CVS) has issued an urgent, nationwide/worldwide recall of its Tenderflow™ Pediatric Arterial Cannulae involving 21 lot codes. Terumo received five reports of ...

Dublin, Dec. 26, 2022 (GLOBE NEWSWIRE) -- The "Arterial Cannula Market Size, Share & Trends Analysis Report By Application (ECMO, Cardiopulmonary Bypass Surgery), By Size (20-22 Fr, 35-36 Fr), By ...

The current trend of using two cannulas to place most newborns in respiratory failure on life-sustaining ECMO, one in the right internal jugular vein and a second in the right common carotid artery, ...

Medical device recalls are essential to patient safety, addressing critical issues in devices that may pose health risks. Here are some of the latest recalls reported to the FDA: 1. Baxter recalls ...

CANNULATION of an artery for frequent blood gas analysis, hemodynamic studies and continuous pressure monitoring is becoming a routine part of the care of the critically ill patient. In our experience ...

Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...